Philip J. Ferrone, MD

Philip J. Ferrone, MD, is partner with Vitreoretinal Consultants of New York and professor of ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Articles by Philip J. Ferrone, MD

AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease

ByPhilip J. Ferrone, MD,Sheryl Stevenson,Sydney M Crago

October 28th 2025

A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.

An image of Philip J. Ferrone, MD, at the American Academy of Ophthalmology meeting.

AAO 2025: Trial findings apply gildeuretinol to treat moderate severity Stargardt disease

ByPhilip J. Ferrone, MD,Sydney M Crago,Sheryl Stevenson

October 23rd 2025

Gildeuretinol has also been evaluated in atrophic age-related macular degeneration, said Philip J. Ferrone, MD

Philip J. Ferrone, MD

Articles by Philip J. Ferrone, MD

AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease

AAO 2025: Trial findings apply gildeuretinol to treat moderate severity Stargardt disease

Latest Updated Articles

Trending on Modern Retina

Five-year GALE study data announced

Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5

Q&A: Diana Do shares real world insights on aflibercept 8 mg